Ali Mirazimi

Dr. Ali Mirazimi is an Adjunct Professor at the Department of Laboratory Medicine, Karolinska Institute. His research focuses on molecular pathogenesis of viral hemorrhagic fevers (CCHFV, Ebola) and SARS-CoV-2, including vaccine development, antiviral therapies, and diagnostic tools.

• Coordinated CCHFVaccine consortium for developing vaccines
• Leading IMI/H2020 projects on SARS-CoV-2
• Established 3D organoid infection models

His lab investigates virus-host interactions across human, animal, and tick cells, with recent publications in Nature Communications, Cell, and Nature Microbiology. Key topics include:

• RNA virus dependencies on host factors
• Mechanisms of vascular leakage in VHF
• Programmed cell death during infections
• Biosafe diagnostic systems for outbreak settings

Collaborations include:

• Prof. Friedemann Weber (Germany)
• Prof. Josef Penninger (Austria)
• Prof. Thomas Helleday (Sweden)
• NIH/NIAID partnerships